Abstract
AbstractThe rampant rise of multidrug resistant (MDR) bacterial pathogens poses a severe health threat, necessitating innovative tools to unravel the complex genetic underpinnings of antimicrobial resistance. Despite significant strides in developing genomic tools for detecting resistance genes, a gap remains in analyzing organism-specific patterns of resistance gene co-occurrence. Addressing this deficiency, we developed the Resistance Gene Association and Inference Network (ReGAIN), a novel web-based and command line genomic platform that uses Bayesian network structure learning to identify and map resistance gene networks in bacterial pathogens. ReGAIN not only detects resistance genes using well- established methods, but also elucidates their complex interplay, critical for understanding MDR phenotypes. Focusing on ESKAPE pathogens, ReGAIN yielded a queryable database for investigating resistance gene co-occurrence, enriching resistome analyses, and providing new insights into the dynamics of antimicrobial resistance. Furthermore, the versatility of ReGAIN extends beyond antibiotic resistance genes to include assessment of co-occurrence patterns among heavy metal resistance and virulence determinants, providing a comprehensive overview of key gene relationships impacting both disease progression and treatment outcomes.Graphical Abstract
Publisher
Cold Spring Harbor Laboratory
Reference62 articles.
1. Antimicrobial resistance: a global multifaceted phenomenon
2. Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index
3. 3. Centers for Disease Control and Prevention, U.D.o.H.a.H.S. (2021). Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP), Vol. 2023.
4. Centers for Disease Control and Prevention US Department of Health and Human Services. (2019) Antibiotic Resistance Threats in the United States. U.S. Department of Health and Human Services, CDC.
5. Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics;Colloids Surf B Biointerfaces,2022